<--- Back to Details
First PageDocument Content
Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Antiretroviral drug / Abacavir / Reverse-transcriptase inhibitor / Nevirapine / Efavirenz / Patent / Raltegravir / Chemistry / Organic chemistry / Organofluorides
Date: 2015-04-20 05:17:21
Cyclopropanes
Non-nucleoside reverse transcriptase inhibitors
Antiretroviral drug
Abacavir
Reverse-transcriptase inhibitor
Nevirapine
Efavirenz
Patent
Raltegravir
Chemistry
Organic chemistry
Organofluorides

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

Add to Reading List

Source URL: www.medicinespatentpool.org

Download Document from Source Website

File Size: 338,44 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xVYP - View Document

Herbst-Fachtagung 2018 Donnerstag und Freitag, Oktober 2018 in Mannheim im Dorint Kongresshotel Mannheim FriedrichsringMannheim

Herbst-Fachtagung 2018 Donnerstag und Freitag, Oktober 2018 in Mannheim im Dorint Kongresshotel Mannheim FriedrichsringMannheim

DocID: 1xVX1 - View Document

Absender:  Dorint Kongresshotel Mannheim FriedrichsringMannheim Fax: +100

Absender: Dorint Kongresshotel Mannheim FriedrichsringMannheim Fax: +100

DocID: 1xVUR - View Document

KF  Rundbrief Nr. 3  September

KF Rundbrief Nr. 3 September

DocID: 1xVRn - View Document

VPP Umschlag Mai17 final.indd

VPP Umschlag Mai17 final.indd

DocID: 1xVR7 - View Document